Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.5 EUR | -0.56% | +1.99% | +49.09% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.09% | 5.07B | |
+42.69% | 749B | |
+38.56% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.87% | 248B | |
-2.62% | 214B | |
+11.19% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment